Stada expands its business activities into Myanmar

FRANKFURT Dec 16 (Reuters) - German generic drug maker
Stada on Monday said it would start producing
medicines in Myanmar from the end of 2015 at a new factory which
is to be built in Yangon.

Stada, which said it was one of the first western
pharmaceutical companies to take up activities in the country,
said it had founded Stada Myanmar Joint Venture Co. Ltd. for
this purpose.

The license agreement gives Stada the option of taking over
the company at a later date. Until then, the country will be
supplied with generic and branded products from its Vietnamese
production facilities, Stada said on Monday.

"Now that the country has opened up, the supply of medicines
in the market with a population of 60 million shows substantial
pent-up demand, particularly for high-quality, low-cost
medicines," chief executive Hartmut Retzlaff said in a
statement.

(Reporting by Edward Taylor; Editing by Victoria Bryan)

http://www.information.myanmaronlinecentre.com/stada-expands-its-business-activities-into-myanmar/